Schwannomas are the most common nerve sheath tumor. They can occur in anyone but are also linked to a hereditary condition known as Neurofibromatosis Type II (NF2). With an urgent need for new treatments, an international team of scientists showed that after just 21 days of two experimental drugs being administered, tumor growth can be strongly and significantly reduced.